Flaxseed Lignans protect older women from hormone dependent breast cancer

February 13, 2008

Scientists at the world-renowned Karolinska Institute in Stockholm evaluated data on 51,823 postmenopausal women in the Swedish Mammography Cohort. They found that women in the top 25% of Flaxseed Lignan intake reduced their risk of developing estrogen or progesterone (hormone dependent) breast cancer by 17%. Protection was strongest for women using hormone replacement therapy. The study is published online ahead of print January 22nd, 2008 on the website of the British Journal of Cancer.
Note; The Swedish Mammography Cohort is a large population-based cohort of over 60,000 women aimed to assess relationships between a number of modifiable factors and the occurrence of several major chronic diseases. Modifiable factors would include smoking, weight, physical activity, alcohol intake. The conditions they are looking at include a number of cancers, heart attack, stroke, cataracts, osteoporosis, and causes of death. The Karolinska Institute is a major medical university that also has a hospital and clinics. It appoints the laureates for the Nobel Prize in medicine and physiology.

Harvard teaching hospital strongly supports the healthy protection derived from Fish Oils

Massachusetts General Hospital is a teaching hospital of Harvard Medical School. Scientists from their Department of Medicine state that the most definite beneficial short term result of consuming Fish Oils is preventing sudden cardiac death. They state it is apparent that the long-term benefit is preventing atherosclerosis (clogging and hardening of the arteries). The review is published in the January 2008 issue of the journal Current Vascular Pharmacology.